Skip to main content
Equibles

Parallel Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1690010 SAN FRANCISCO, CA
Back to GILD Full portfolio

Position in GILD

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$9,710,745
-$879,145 QoQ
Shares Held
76,862
+1.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#438
of 2,284 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Parallel Advisors, LLC holds $119,634,223 across 18 Drug Manufacturers - General names. GILD ranks #4 (8.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 31,933 $38,301,401
2 ABBV
AbbVie Inc.
 100,846 $25,376,887
3 JNJ
Johnson & Johnson
 83,035 $21,088,398
4 GILD
Gilead Sciences, Inc.
This page 		76,862 $9,710,745
5 MRK
Merck & Co., Inc.
 66,774 $8,580,459
6 AMGN
Amgen Inc
 11,139 $4,033,654
7 NVO
Novo Nordisk A S
 56,877 $2,726,683
8 NVS
Novartis AG
 15,640 $2,451,100

All Filings in GILD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,710,745 76,862
2026-03-31 $10,589,890 75,984
2025-12-31 $9,631,898 78,474
2025-09-30 $8,266,170 74,470
2025-06-30 $3,906,060 35,231
2025-03-31 $3,828,076 34,164
2024-12-31 $3,421,384 37,040
2024-09-30 $3,294,744 39,298
2024-06-30 $3,987,819 58,123
2024-03-31 $3,352,945 45,774
2023-12-31 $3,510,649 43,336
2023-09-30 $3,232,087 43,129
2023-06-30 $3,433,468 44,550
2023-03-31 $3,662,793 44,146
2022-12-31 $3,626,132 42,238
2022-09-30 $2,753,039 44,627
2022-06-30 $2,283,694 36,947
2022-03-31 $2,108,037 35,459
2021-12-31 $2,414,572 33,254
2021-09-30 $2,165,280 30,999
2021-06-30 $2,020,490 29,342
2021-03-31 $1,745,462 27,007
2020-12-31 $1,525,596 26,186
2020-09-30 $1,683,128 26,636
2020-06-30 $2,187,942 28,437
2020-03-31 $2,098,812 28,074